Morgan Stanley: Globus Medical GMED Historial de posiciones en acciones
Comprado
Mantenidas
Vendido
| Trimestre | Valor de mercado | Estado | Acciones |
Cambio en la posición | Valor operado | Peso en el portafolio | Puesto en el portafolio | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | USD 164 M | Compra |
2,187,838
+1,093,085
| +100% | +USD 86.6 M | 0.01% | 1182 |
|
|
2026
Q2 | USD 86.5 M | Compra |
1,094,753
+34,253
| +3% | +USD 2.91 M | ﹤0.01% | 1694 |
|
|
2026
Q1 | USD 91.4 M | Compra |
1,060,500
+136,125
| +15% | +USD 12.2 M | 0.01% | 1522 |
|
|
2025
Q4 | USD 80.7 M | Compra |
924,375
+83,371
| +10% | +USD 6.33 M | ﹤0.01% | 1637 |
|
|
2025
Q3 | USD 48.2 M | Venta |
841,004
-30,607
| -4% | -USD 1.76 M | ﹤0.01% | 2041 |
|
|
2025
Q2 | USD 51.4 M | Compra |
871,611
+188,510
| +28% | +USD 12.2 M | ﹤0.01% | 1909 |
|
|
2025
Q1 | USD 50 M | Venta |
683,101
-63,060
| -8% | -USD 5.21 M | ﹤0.01% | 1816 |
|
|
2024
Q4 | USD 61.7 M | Compra |
746,161
+158,674
| +27% | +USD 12.5 M | ﹤0.01% | 1638 |
|
|
2024
Q3 | USD 42 M | Venta |
587,487
-93,277
| -14% | -USD 6.58 M | ﹤0.01% | 1999 |
|
|
2024
Q2 | USD 46.6 M | Venta |
680,764
-35,220
| -5% | -USD 2.1 M | ﹤0.01% | 1828 |
|
|
2024
Q1 | USD 38.4 M | Compra |
715,984
+24,653
| +4% | +USD 1.33 M | ﹤0.01% | 2011 |
|
|
2023
Q4 | USD 36.8 M | Compra |
691,331
+37,248
| +6% | +USD 1.82 M | ﹤0.01% | 2036 |
|
|
2023
Q3 | USD 32.5 M | Compra |
654,083
+15,504
| +2% | +USD 867 k | ﹤0.01% | 1975 |
|
|
2023
Q2 | USD 38 M | Venta |
638,579
-3,800
| -0.6% | -USD 217 k | ﹤0.01% | 1847 |
|
|
2023
Q1 | USD 36.4 M | Venta |
642,379
-443,910
| -41% | -USD 28.5 M | ﹤0.01% | 1843 |
|
|
2022
Q4 | USD 80.7 M | Venta |
1,086,289
-123,962
| -10% | -USD 8.44 M | 0.01% | 1173 |
|
|
2022
Q3 | USD 72.1 M | Venta |
1,210,251
-127,788
| -10% | -USD 7.7 M | 0.01% | 1079 |
|
|
2022
Q2 | USD 75.1 M | Compra |
1,338,039
+335,692
| +33% | +USD 22.1 M | 0.01% | 1100 |
|
|
2022
Q1 | USD 74 M | Compra |
1,002,347
+850,086
| +558% | +USD 59.1 M | 0.01% | 1053 |
|
|
2021
Q4 | USD 11 M | Venta |
152,261
-157,876
| -51% | -USD 11.5 M | ﹤0.01% | 2849 |
|
|
2021
Q3 | USD 23.8 M | Compra |
310,137
+102,448
| +49% | +USD 8.23 M | ﹤0.01% | 1908 |
|
|
2021
Q2 | USD 16.1 M | Compra |
207,689
+10,577
| +5% | +USD 752 k | ﹤0.01% | 2402 |
|
|
2021
Q1 | USD 12.2 M | Venta |
197,112
-42,989
| -18% | -USD 2.72 M | ﹤0.01% | 2445 |
|
|
2020
Q4 | USD 15.7 M | Venta |
240,101
-80,186
| -25% | -USD 4.61 M | ﹤0.01% | 2051 |
|
|
2020
Q3 | USD 15.9 M | Compra |
320,287
+120,895
| +61% | +USD 6.24 M | ﹤0.01% | 1650 |
|
|
2020
Q2 | USD 9.5 M | Compra |
199,392
+144,675
| +264% | +USD 6.98 M | ﹤0.01% | 2018 |
|
|
2020
Q1 | USD 2.33 M | Venta |
54,717
-141,889
| -72% | -USD 7.01 M | ﹤0.01% | 3230 |
|
|
2019
Q4 | USD 11.6 M | Compra |
196,606
+134,160
| +215% | +USD 7.28 M | ﹤0.01% | 2259 |
|
|
2019
Q3 | USD 3.19 M | Venta |
62,446
-23,974
| -28% | -USD 1.14 M | ﹤0.01% | 3354 |
|
|
2019
Q2 | USD 3.66 M | Compra |
86,420
+22,625
| +35% | +USD 982 k | ﹤0.01% | 3246 |
|
|
2019
Q1 | USD 3.15 M | Venta |
63,795
-616,830
| -91% | -USD 27.9 M | ﹤0.01% | 3163 |
|
|
2018
Q4 | USD 29.5 M | Compra |
680,625
+202,569
| +42% | +USD 10.1 M | 0.01% | 1139 |
|
|
2018
Q3 | USD 27.1 M | Venta |
478,056
-48,895
| -9% | -USD 2.57 M | 0.01% | 1408 |
|
|
2018
Q2 | USD 26.6 M | Compra |
526,951
+170,673
| +48% | +USD 8.9 M | 0.01% | 1381 |
|
|
2018
Q1 | USD 17.8 M | Compra |
356,278
+27,537
| +8% | +USD 1.29 M | ﹤0.01% | 1780 |
|
|
2017
Q4 | USD 13.5 M | Compra |
328,741
+13,622
| +4% | +USD 477 k | ﹤0.01% | 2083 |
|
|
2017
Q3 | USD 9.37 M | Compra |
315,119
+109,458
| +53% | +USD 3.34 M | ﹤0.01% | 2346 |
|
|
2017
Q2 | USD 6.82 M | Venta |
205,661
-116,520
| -36% | -USD 3.66 M | ﹤0.01% | 2536 |
|
|
2017
Q1 | USD 9.5 M | Venta |
322,181
-49,348
| -13% | -USD 1.35 M | ﹤0.01% | 2240 |
|
|
2016
Q4 | USD 9.22 M | Compra |
371,529
+146,048
| +65% | +USD 3.32 M | ﹤0.01% | 2338 |
|
|
2016
Q3 | USD 5.09 M | Venta |
225,481
-42,921
| -16% | -USD 1.01 M | ﹤0.01% | 2639 |
|
|
2016
Q2 | USD 6.4 M | Venta |
268,402
-207,588
| -44% | -USD 4.98 M | ﹤0.01% | 2382 |
|
|
2016
Q1 | USD 11.3 M | Compra |
475,990
+400,465
| +530% | +USD 9.8 M | ﹤0.01% | 1763 |
|
|
2015
Q4 | USD 2.1 M | Compra |
75,525
+21,202
| +39% | +USD 532 k | ﹤0.01% | 3449 |
|
|
2015
Q3 | USD 1.12 M | Venta |
54,323
-61,227
| -53% | -USD 1.55 M | ﹤0.01% | 4014 |
|
|
2015
Q2 | USD 2.97 M | Compra |
115,550
+56,217
| +95% | +USD 1.42 M | ﹤0.01% | 3254 |
|
|
2015
Q1 | USD 1.5 M | Venta |
59,333
-119,167
| -67% | -USD 2.9 M | ﹤0.01% | 3819 |
|
|
2014
Q4 | USD 4.24 M | Venta |
178,500
-172,315
| -49% | -USD 3.82 M | ﹤0.01% | 2882 |
|
|
2014
Q3 | USD 6.9 M | Venta |
350,815
-29,444
| -8% | -USD 606 k | ﹤0.01% | 2342 |
|
|
2014
Q2 | USD 9.1 M | Compra |
380,259
+140,458
| +59% | +USD 3.39 M | ﹤0.01% | 2117 |
|
|
2014
Q1 | USD 6.38 M | Compra |
239,801
+147,854
| +161% | +USD 3.51 M | ﹤0.01% | 2351 |
|
|
2013
Q4 | USD 1.86 M | Compra |
91,947
+34,990
| +61% | +USD 650 k | ﹤0.01% | 3433 |
|
|
2013
Q3 | USD 995 k | Compra |
56,957
+12,247
| +27% | +USD 212 k | ﹤0.01% | 3792 |
|
|
2013
Q2 | USD 754 k | Compra |
+44,710
| Nuevas | +USD 690 k | ﹤0.01% | 3948 |
|
Otros fondos que tienen GMED en su portafolio
Posición de Morgan Stanley en GMED: resumen de T3 2026
Morgan Stanley aumentó su participación en Globus Medical (GMED) en 100% durante T3 2026, al comprar aproximadamente USD 86.6 M y elevar la posición a 2,187,838 acciones con un valor de USD 164 M. La posición representa 0.01% del portafolio y ocupa el puesto #1182.
Morgan Stanley reportó por primera vez una posición en GMED en T2 2013 y desde entonces la ha mantenido en 54 trimestres. Al cierre de T3 2026, 617 fondos que sigue Wall St. Rank mantienen una posición en GMED.
- Al cierre de T3 2026, Morgan Stanley tenía 2,187,838 acciones de Globus Medical con un valor de USD 164 M.
- Morgan Stanley compró 1,093,085 acciones de Globus Medical en T3 2026, por un monto estimado de USD 86.6 M.
- Globus Medical representó el 0.01% del portafolio de Morgan Stanley en T3 2026 y fue su posición número 1182.
- Morgan Stanley reportó por primera vez una posición en Globus Medical en T2 2013 y desde entonces la ha mantenido en 54 trimestres.
- Al cierre de T3 2026, 617 fondos que sigue Wall St. Rank tenían Globus Medical en su portafolio.
Según el informe 13F de Morgan Stanley correspondiente a T3 2026, presentado el 13 nov 2026.